Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5776953

O=C(CCc1cnoc1-c1ccc(F)cc1)N(Cc1cccnc1)Cc1cccnc1.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.48
HTR5A P47898 4/20 0.42
HTR1A P08908 1/20 0.42
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
HTR1D P28221 1/20 0.42
HTR1B P28222 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
HTR7 P34969 1/20 0.42
ADRA1B P35368 1/20 0.42
DRD3 P35462 1/20 0.42
HTR2B P41595 1/20 0.42
CYP3A4 P08684 3/20 0.40
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
FNTA P49354 1/20 0.38
FNTB P49356 1/20 0.38
NAMPT P43490 3/20 0.37
LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5774481 0.84 ALDH1A1 (0.42) HTR5ACYP3A4ALDH1A1MAPTFNTA
SCHEMBL5773324 0.84 CYP3A4 (0.41) PKMHTR5AHTR1ADRD2DRD4
Trifluoroacetic Acid SCHEMBL5775660 0.84 HTR5A (0.47) HTR5AHTR1ADRD2DRD4HTR1D
Trifluoroacetic Acid SCHEMBL5770769 0.83 HTR5A (0.38) HTR5AALDH1A1MAPTNAMPTLMNA
Trifluoroacetic Acid SCHEMBL5773317 0.83 CYP3A4 (0.53) CYP3A4ALDH1A1MAPTLMNA
Trifluoroacetic Acid SCHEMBL5771354 0.83 ALDH1A1 (0.49) HTR5ACYP3A4ALDH1A1NAMPTLMNA
SCHEMBL5771361 0.79 NAMPT (0.42) CYP3A4NAMPTTBXAS1
SCHEMBL5774452 0.78 TSHR (0.44) HTR5AHTR1ADRD2DRD4HTR1D
SCHEMBL5774168 0.77 ALDH1A1 (0.45) CYP3A4ALDH1A1LMNANPSR1TSHR
SCHEMBL5769884 0.76 NPC1 (0.54) ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR PKM 2534/4885HTR5A 3314/4885HTR1A 2719/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 PKM 1824/4885HTR5A 3051/4885HTR1A 1650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.